Bruker AXS Exhibits New QUANTAX(TM) QUAD EDS System at Pittcon 2006.ORLANDO, Fla. -- At Pittcon 2006, Bruker AXS Microanalysis microanalysis /mi·cro·anal·y·sis/ (-ah-nal´i-sis) the chemical analysis of minute quantities of material. microanalysis the chemical analysis of minute quantities of material. will exhibit its recently announced QUANTAX(TM) QUAD ultra-fast and sensitive EDS (Electronic Data Systems, Plano, TX, www.eds.com) Founded in 1962 by H. Ross Perot (independent candidate for the President of the U.S. in 1992), EDS is the largest outsourcing and data processing services organization in the country. system for X-ray microanalysis on electron microscopes. QUANTAX(TM) QUAD features the unique XFlash(R) QUAD detector -- the first four-channel 40 mm(2) Silicon Drift Detector (SDD (Software Design Description) The architecture of an information system. See IDD. ) for Energy-Dispersive Spectroscopy (EDS) systems mounted on electron microscopes. Powered by ESPRIT(TM) software, the QUANTAX QUAD delivers significantly faster EDS results across a broad range of applications. It is especially suitable for field emission scanning electron microscopes, environmental and low vacuum scanning electron microscopes. The new high-end XFlash QUAD detector complements the existing Bruker AXS QUANTAX EDS product line. Four independently operating 10 mm(2) Silicon Drift Detectors (SDDs) with integrated anodes and FETs form the heart of the XFlash QUAD detector. This arrangement provides the high energy resolution of a single 10 mm(2) crystal at four times the count rate, accepting maximum input count rates in excess of 2,000,000 cps. Cooled by Peltier elements, the XFlash QUAD detector requires no liquid nitrogen and is vibration and maintenance-free. Standard energy resolution is better than 133eV (MnKa) at 10,000 cps, and energy resolution of better than 127 (MnKa, 10,000 cps) is available upon request. Thomas Schuelein, Vice President for Microanalysis at Bruker AXS, stated: "This cutting-edge new product fits right into our broader EDS strategy, as it complements our already existing range of industry-leading Silicon Drift Detectors. While our proven 10 and 30 mm(2) single-channel XFlash SDDs are expected to remain the standard for the vast majority of EDS applications, the unique new XFlash QUAD SDD is ideal for optimizing count rate at low beam current conditions and helps make new analysis techniques, like spectral imaging, even more efficient and powerful. All of our QUANTAX EDS customers can upgrade to the XFlash QUAD in the future, should their applications require this performance." For more information about the new QUANTAX QUAD and the complete line of X-ray microanalysis systems and detectors offered by Bruker AXS Microanalysis, please visit www.bruker-axs-ma.com and the Bruker AXS Pittcon booth #3155 in Orlando, FL, March 13-16, 2006. ABOUT BRUKER BIOSCIENCES (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BRKR BRKR Breaker ) Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. , headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker AXS is a leading developer and provider of life science, materials research and industrial X-ray analysis tools. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. . For more information, please visit www.bruker-biosciences.com CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, exposure to currency fluctuations, changes in governmental regulations, capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. and government funding policies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K, our most recent quarterly reports on Form 10-Q, and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion